or Try an Advanced Search...

    Technical Analysis for MYMD - MyMD Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    F 1.84 0.00% 0.00
    MYMD closed unchanged on Monday, July 1, 2024, on 33 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical MYMD trend table...
    Date Alert Name Type % Chg
    Bollinger Band Squeeze Range Contraction 0.00%
    Gapped Up Strength 0.00%
    Oversold Stochastic Weakness 0.00%
    Stochastic Buy Signal Bullish 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    Doji - Bullish? Reversal 0.00%
    New 52 Week Low Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    MACD Bearish Signal Line Cross Bearish 0.55%
    New 52 Week Closing Low Bearish 0.55%
    Older End-of-Day Signals for MYMD ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakout about 9 hours ago
    1.5x Volume Pace about 10 hours ago
    Down 3% about 10 hours ago
    Down 2 % about 10 hours ago
    Down 1% about 10 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    MYMD Chart by TradingView
    Basic chart:

    Profile

    MyMD Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, engages in the development of drug products in the targeting of aging and age-related diseases; autoimmune diseases; and chronic pain, anxiety, and sleep disorders. It commercializes MYMD-1, a novel therapeutic to impact conditions related to immunometabolic dysregulation; and SUPERA-1R, a synthetic cannabidiol that offers bioavailability and potency than botanicals. The company was incorporated in 2014 and is based in Tampa, Florida.
    Classification
    Sector: Healthcare
    Industry: Medical Instruments & Supplies
    Keywords: Medicine Pharmaceutical Immunology Health Sciences Autoimmune Disease Medication Health Care Cannabis Disorders Euphoriants Chronic Pain Entheogens Autoimmunity Drug Products Cannabidiol Age Related Diseases Appetite Stimulants

    Is MYMD a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 26 Latest Key Hires & Board Changes In Cannabis Industry: Canopy Growth, Acreage And More
    Jun 21 MyMD Pharmaceuticals files to sell 473,841 shares of common stock for holders
    Jun 17 MyMD Pharmaceuticals Appoints Accomplished Biopharmaceutical Leader and Current Board Member, Mitchell Glass, M.D. as President and Chief Medical Officer
    May 21 PharmaCyte Biotech announces $7 million strategic investment in MYMD
    May 21 MyMD Pharmaceuticals Secures Strategic Investments
    Apr 9 Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Apr 9 Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket
    Mar 5 MyMD Pharmaceuticals said it has regained compliance with Nasdaq rules
    Mar 5 MyMD Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued Listing
    Feb 13 MyMD Pharmaceuticals down after announcing reverse stock split
    See more MYMD news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 63.87
    52 Week Low 1.7501
    Average Volume 71,045
    200-Day Moving Average 6.28
    50-Day Moving Average 2.30
    20-Day Moving Average 1.98
    10-Day Moving Average 1.94
    Average True Range 0.16
    RSI (14) 39.76
    ADX 10.34
    +DI 22.66
    -DI 22.69
    Chandelier Exit (Long, 3 ATRs) 1.77
    Chandelier Exit (Short, 3 ATRs) 2.22
    Upper Bollinger Bands 2.24
    Lower Bollinger Band 1.73
    Percent B (%b) 0.22
    BandWidth 25.70
    MACD Line -0.11
    MACD Signal Line -0.10
    MACD Histogram -0.0025
    Fundamentals Value
    Market Cap 93.66 Million
    Num Shares 50.9 Million
    EPS -0.17
    Price-to-Earnings (P/E) Ratio -10.82
    Price-to-Sales 0.00
    Price-to-Book 0.47
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.07
    Resistance 3 (R3) 2.08 2.00 2.03
    Resistance 2 (R2) 2.00 1.94 2.00 2.02
    Resistance 1 (R1) 1.92 1.90 1.88 1.92 2.01
    Pivot Point 1.85 1.85 1.83 1.84 1.85
    Support 1 (S1) 1.76 1.79 1.73 1.76 1.67
    Support 2 (S2) 1.69 1.75 1.69 1.66
    Support 3 (S3) 1.61 1.69 1.65
    Support 4 (S4) 1.61